Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis

(CCG)1-2 polymorphism and contribution to founder effect

Kazuyuki Mizushima, Mitsunori Watanabe, Ikuko Kondo, Koichi Okamoto, Masami Shizuka, Koji Abe, Masashi Aoki, Mikio Shoji

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Spinocerebellar ataxia type 2 is a familial spinocerebellar ataxia with autosomal dominant inheritance. The gene responsible was recently cloned and this disorder was found to be the result of a CAG expansion in its open reading frame. We analysed 13 SCA2 patients in seven unrelated families in Gunma Prefecture, Japan. In four of the seven families, we detected CCG or CCGCCG interruptions in only the expanded alleles. Cosegregation of these polymorphisms with SCA2 patients was established within each family. Together with the results of haplotype analyses, we considered that at least two founders were present in our area and that these (CCG)1-2 polymorphisms may make analysis of founder effects easier. By sequencing analysis we found that although the number of the long CAG repeat varied in each subclone of expanded alleles, these polymorphisms did not change their configuration. This finding suggests that CCG or CCGCCG sequences are stable when surrounded by the long CAG repeat and a single CAG. Moreover, the presence of these polymorphisms may lead to miscounting the repeat size by conventional estimation using a size marker such as an M13 sequencing ladder. Therefore we should consider these polymorphisms and accurately determine the repeat size by sequencing.

Original languageEnglish
Pages (from-to)112-114
Number of pages3
JournalJournal of Medical Genetics
Volume36
Issue number2
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Founder Effect
Spinocerebellar Ataxias
Haplotypes
Alleles
Genes
Open Reading Frames
Japan

Keywords

  • CCG repeat polymorphism
  • Founder effect
  • Spinocerebellar ataxia type 2

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis : (CCG)1-2 polymorphism and contribution to founder effect. / Mizushima, Kazuyuki; Watanabe, Mitsunori; Kondo, Ikuko; Okamoto, Koichi; Shizuka, Masami; Abe, Koji; Aoki, Masashi; Shoji, Mikio.

In: Journal of Medical Genetics, Vol. 36, No. 2, 1999, p. 112-114.

Research output: Contribution to journalArticle

Mizushima, K, Watanabe, M, Kondo, I, Okamoto, K, Shizuka, M, Abe, K, Aoki, M & Shoji, M 1999, 'Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis: (CCG)1-2 polymorphism and contribution to founder effect', Journal of Medical Genetics, vol. 36, no. 2, pp. 112-114.
Mizushima, Kazuyuki ; Watanabe, Mitsunori ; Kondo, Ikuko ; Okamoto, Koichi ; Shizuka, Masami ; Abe, Koji ; Aoki, Masashi ; Shoji, Mikio. / Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis : (CCG)1-2 polymorphism and contribution to founder effect. In: Journal of Medical Genetics. 1999 ; Vol. 36, No. 2. pp. 112-114.
@article{a69d9096698b411091137283ac995940,
title = "Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis: (CCG)1-2 polymorphism and contribution to founder effect",
abstract = "Spinocerebellar ataxia type 2 is a familial spinocerebellar ataxia with autosomal dominant inheritance. The gene responsible was recently cloned and this disorder was found to be the result of a CAG expansion in its open reading frame. We analysed 13 SCA2 patients in seven unrelated families in Gunma Prefecture, Japan. In four of the seven families, we detected CCG or CCGCCG interruptions in only the expanded alleles. Cosegregation of these polymorphisms with SCA2 patients was established within each family. Together with the results of haplotype analyses, we considered that at least two founders were present in our area and that these (CCG)1-2 polymorphisms may make analysis of founder effects easier. By sequencing analysis we found that although the number of the long CAG repeat varied in each subclone of expanded alleles, these polymorphisms did not change their configuration. This finding suggests that CCG or CCGCCG sequences are stable when surrounded by the long CAG repeat and a single CAG. Moreover, the presence of these polymorphisms may lead to miscounting the repeat size by conventional estimation using a size marker such as an M13 sequencing ladder. Therefore we should consider these polymorphisms and accurately determine the repeat size by sequencing.",
keywords = "CCG repeat polymorphism, Founder effect, Spinocerebellar ataxia type 2",
author = "Kazuyuki Mizushima and Mitsunori Watanabe and Ikuko Kondo and Koichi Okamoto and Masami Shizuka and Koji Abe and Masashi Aoki and Mikio Shoji",
year = "1999",
language = "English",
volume = "36",
pages = "112--114",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis

T2 - (CCG)1-2 polymorphism and contribution to founder effect

AU - Mizushima, Kazuyuki

AU - Watanabe, Mitsunori

AU - Kondo, Ikuko

AU - Okamoto, Koichi

AU - Shizuka, Masami

AU - Abe, Koji

AU - Aoki, Masashi

AU - Shoji, Mikio

PY - 1999

Y1 - 1999

N2 - Spinocerebellar ataxia type 2 is a familial spinocerebellar ataxia with autosomal dominant inheritance. The gene responsible was recently cloned and this disorder was found to be the result of a CAG expansion in its open reading frame. We analysed 13 SCA2 patients in seven unrelated families in Gunma Prefecture, Japan. In four of the seven families, we detected CCG or CCGCCG interruptions in only the expanded alleles. Cosegregation of these polymorphisms with SCA2 patients was established within each family. Together with the results of haplotype analyses, we considered that at least two founders were present in our area and that these (CCG)1-2 polymorphisms may make analysis of founder effects easier. By sequencing analysis we found that although the number of the long CAG repeat varied in each subclone of expanded alleles, these polymorphisms did not change their configuration. This finding suggests that CCG or CCGCCG sequences are stable when surrounded by the long CAG repeat and a single CAG. Moreover, the presence of these polymorphisms may lead to miscounting the repeat size by conventional estimation using a size marker such as an M13 sequencing ladder. Therefore we should consider these polymorphisms and accurately determine the repeat size by sequencing.

AB - Spinocerebellar ataxia type 2 is a familial spinocerebellar ataxia with autosomal dominant inheritance. The gene responsible was recently cloned and this disorder was found to be the result of a CAG expansion in its open reading frame. We analysed 13 SCA2 patients in seven unrelated families in Gunma Prefecture, Japan. In four of the seven families, we detected CCG or CCGCCG interruptions in only the expanded alleles. Cosegregation of these polymorphisms with SCA2 patients was established within each family. Together with the results of haplotype analyses, we considered that at least two founders were present in our area and that these (CCG)1-2 polymorphisms may make analysis of founder effects easier. By sequencing analysis we found that although the number of the long CAG repeat varied in each subclone of expanded alleles, these polymorphisms did not change their configuration. This finding suggests that CCG or CCGCCG sequences are stable when surrounded by the long CAG repeat and a single CAG. Moreover, the presence of these polymorphisms may lead to miscounting the repeat size by conventional estimation using a size marker such as an M13 sequencing ladder. Therefore we should consider these polymorphisms and accurately determine the repeat size by sequencing.

KW - CCG repeat polymorphism

KW - Founder effect

KW - Spinocerebellar ataxia type 2

UR - http://www.scopus.com/inward/record.url?scp=0033064225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033064225&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 112

EP - 114

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 2

ER -